As Tony Abbott's top business adviser Maurice Newman sees it, there's a pressing need for a sensible conversation in Australia about the country's economic future. Some difficult decisions need to follow. If the country can't do it, the rest of the world will make the de...

The Pfizer-Allergan merger -- a deal that would have been worth $160 billion and the largest in pharma history -- has officially been called off. Business Insider's Porita Crowe points out that six investment banks will be missing out in more than $200 million in fees...

Australia's $8.1 trillion property market demands a Royal Commission and subsequent intervention, a new research paper claims. A special report compiled by UNSW found that soaring prices present a "triple crisis" to the Australian economy that risks worsening ineq...

The pharmaceutical company Mylan has been in the hot seat with members of Congress over the price of the EpiPen. The device, used in emergencies to treat severe allergic reactions, costs more than 500% more than it did when Mylan acquired it in 2007. Mo...

Simple yet powerful tips that can help any type of business leader. More Â»